Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology

Since December 2019, an outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, has spread throughout the world. Coagulation dysfunction is one of the major causes of death in patients with severe COVID-19. Several recent observations in Algeria and elsewhere maintain that a pulmonary embol...

Descripción completa

Detalles Bibliográficos
Autores principales: Chekkal, M., Deba, T., Hadjali, S., Lamara, H., Oulaa, H., Zouai, K., Hariti, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS on behalf of Société française de transfusion sanguine (SFTS). 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532757/
https://www.ncbi.nlm.nih.gov/pubmed/33022374
http://dx.doi.org/10.1016/j.tracli.2020.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532757/
https://www.ncbi.nlm.nih.gov/pubmed/33022374
http://dx.doi.org/10.1016/j.tracli.2020.09.004

Ejemplares similares